glp-1 cardiovascular outcomes trial august 2025 Kidney and Among Patients With CKD Receiving Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Association of GLP-1 inhibitors with
Description
ELIXA Investigators

GLP-1 receptor agonists, like Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for diabetes management, show promising potential in treating psoriasis and psoriatic arthritis (PsA)

Weight loss and metabolic risk in obese children

However, if your appetite is very low, even 20 to 25 grams per meal is a win

Other options include psyllium husk, methylcellulose, or other soluble fiber supplements can also help relieve constipation, but they may be more likely to cause bloating, gas, or other GI symptoms

Two propensity score matched observational studies have been conducted to date, either evaluating suicidality risk in patients using semaglutide vs non-GLP-1RA glucose-lowering agents, or in those using any GLP-1RA vs users of dipeptidyl peptidase-4 (DPP-4) inhibitors
